An evaluation is due to start on 6 September 2021 into screening babies for severe combined immunodeficiency (SCID) in England. This article explains about a separate pathway for premature babies which have been screened for SCID as part of the evaluation.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is now scheduled to start from September 2021.
The revised standards have been published and will be implemented from 1 April.
Information gained from an NHS evaluation will inform a final UK National Screening Committee recommendation on whether screening for SCID should become part of the newborn blood spot screening programme.
Members of the newborn blood spot (NBS) screening programme team had an exciting opportunity recently to present at a screening conference in Hangzhou in China. NBS programme manager Christine Cavanagh talks about the trip.
...including the 4 metabolic conditions added in January 2015: maple syrup urine disease isovaleric acidaemia glutaric aciduria type 1 homocystinuria The standards measure important points in the screening journey, including...
...to maximise accuracy of test and timeliness of referral remove laboratory accreditation standards (8 and 10) as they are in the service specification (Section 7a) develop an audit tool to...
...that the blood has soaked through to the back of the filter paper don’t add multiple small drops of blood to fill the circle don’t apply blood to both sides...
...guidelines for newborn blood spot sampling our latest annual data report new inherited metabolic disease (IMD) leaflets for parents The quick guide version of the revised newborn blood spot sampling...
...for referral, meaning the case would have been missed. Thankfully, in this instance, sample procedures were followed effectively and efficiently. Both the initial sample and the repeat sample were taken...